Antimetastatic effects associated with anticoagulant properties of heparin and chemically modified heparin species in a mouse mammary tumor model

Oncology Reports

Volumn 3, Issue 1, 1996, Pages 219-222

  Alonso, Danielf ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

heparin; heparinoid; mammary tumor; metastasis; procoagulant activity

Indexed keywords

ANTIMETASTATIC AGENT; BLOOD CLOTTING INHIBITOR; HEPARIN; HEPARIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030025931     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.1.219     Document Type: Article

References (2)

1. Rickles FR and Edwards RL: Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62: 14-31,1983.
2. Al-Mondhiry H: Tumor interaction with hemostasis: the rationale for use of platelet inhibitors and anticoagulants in the treatment of cancer. Am J Hematol 16: 193-202, 1984.